New Deakin trial explores gut-based therapy for Long COVID
May 05, 2026
May 05, 2026
GEELONG, Australia, May 5 -- Deakin University issued the following news release:
* * *
New Deakin trial explores gut-based therapy for Long COVID
*
Researchers at Deakin University's Food and Mood Centre have begun a clinical trial to explore whether targeting the gut microbiome may be a safe and feasible potential treatment approach for people living with Long COVID.
The GLOW Trial is investigating whether faecal microbiota . . .
* * *
New Deakin trial explores gut-based therapy for Long COVID
*
Researchers at Deakin University's Food and Mood Centre have begun a clinical trial to explore whether targeting the gut microbiome may be a safe and feasible potential treatment approach for people living with Long COVID.
The GLOW Trial is investigating whether faecal microbiota . . .